Susquehanna International Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-28,746
Closed -$31K 14488
2022
Q1
$31K Buy
28,746
+17,205
+149% +$13K ﹤0.01% 12498
2021
Q4
$8K Buy
+11,541
New +$9.34K ﹤0.01% 12963
2021
Q2
Sell
-88,003
Closed -$184K 13570
2021
Q1
$184K Buy
88,003
+75,126
+583% +$156K ﹤0.01% 11494
2020
Q4
$16K Buy
+12,877
New +$15.4K ﹤0.01% 10899
2020
Q3
Sell
-19,814
Closed -$23K 11388
2020
Q2
$23K Buy
19,814
+4,367
+28% +$4.04K ﹤0.01% 9906
2020
Q1
$13K Buy
+15,447
New +$16.4K ﹤0.01% 10012
2019
Q4
Sell
-23,649
Closed -$33K 10989
2019
Q3
$33K Buy
23,649
+3,578
+18% +$5.05K ﹤0.01% 9881
2019
Q2
$30K Buy
+20,071
New +$31K ﹤0.01% 9946
2017
Q2
Sell
-11,224
Closed -$22K 10055
2017
Q1
$22K Buy
+11,224
New +$23.8K ﹤0.01% 8719
2015
Q4
Sell
-65,740
Closed -$139K 10177
2015
Q3
$139K Sell
65,740
-45,856
-41% -$89.3K ﹤0.01% 8966
2015
Q2
$221K Buy
+111,596
New +$316K ﹤0.01% 9120
2014
Q3
Sell
-10,294
Closed -$120K 10114
2014
Q2
$120K Buy
+10,294
New +$117K ﹤0.01% 9355

Other funds holding MBII

Susquehanna International Group's MBII Position: Q2 2022 in Review

Susquehanna International Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 28,746 shares — an estimated $31K sold.

Susquehanna International Group first reported a position in MBII in Q2 2014 and held it in 12 quarters. The position peaked at $221K in Q2 2015. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Susquehanna International Group reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 28,746 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $31K.
  • Susquehanna International Group first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 12 quarters.
  • Susquehanna International Group's Marrone Bio Innovations, Inc. position peaked at $221K in Q2 2015.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.